Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

NCT06865144 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

Primary Open Angle Glaucoma or Ocular Hypertension

Interventions

DRUG: Netarsudil ophthalmic solution 0.02%
DRUG: Artificial tears

Sponsor

East Coast Institute for Research

Collaborators

[object Object]
[object Object]